The Effect of Cord Milking on Hemodynamic Status of Preterm Infants

Sponsor
Walid El-Naggar (Other)
Overall Status
Unknown status
CT.gov ID
NCT01487187
Collaborator
(none)
73
1
2
74
1

Study Details

Study Description

Brief Summary

Very preterm babies frequently develop problems with their blood circulation during the first few days after birth. These circulation problems could affect the oxygen and blood flow to their brain and lead to effects such as bleeding in the head or delayed developmental milestones later in life. Currently the care for such problems may include transfusion of intravenous fluids or blood to the baby and/or giving the baby medications that can help circulation.

The current practice at the delivery of these babies is to immediately clamp their umbilical cords after birth. Recent research studies have shown that giving more of the baby's own blood to them at birth by delayed cord clamping (waiting for clamping the cord for about 30-90 seconds) or by milking the cord, may reduce the number of blood transfusions that these babies may need later on. It may also improve their initial blood pressure and reduce the chances of bleeding in their heads.

More research is needed to prove if either delayed cord clamping or milking the cord at birth will be better in terms of improving these babies' health.

The aim of this study is to find out if adding some blood to these babies' circulation, through milking the cord at birth, could prevent or reduce the possible problems with blood circulation and the reduced blood flow to the brain that some of these babies may have after birth.

The investigators will also investigate if milking the cord at birth could improve their long-term developmental outcome.

Hypothesis: In preterm infants less than 31 weeks' gestation, milking the umbilical cord 3 times prior to clamping, compared to immediate clamping after birth will improve systemic blood flow (as assessed by improving superior vena cava flow measured by heart ultrasound in the first 24 hours after birth)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Milking the umbilical cord at birth
  • Procedure: immediate umbilical cord clamping
N/A

Detailed Description

Eligible mothers will be randomized prior to delivery once preterm labour is established (cervical dilatation > 4cm and preterm birth is considered inevitable or delivery is indicated for maternal or fetal indications) to either milking of the umbilical cord of their infants (intervention group) or to clamp the cord as per standard practice (currently it is the immediate cord clamping) after birth (control group). Randomization will be done in variable block sizes and will be concealed by using opaque envelopes prepared ahead of time from a randomization table. Envelopes will be opened before the time of delivery.

Study Design

Study Type:
Interventional
Actual Enrollment :
73 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effect of Umbilical Cord Milking on Hemodynamic Status of Preterm Infants: a Randomized Controlled Trial
Study Start Date :
Nov 1, 2011
Anticipated Primary Completion Date :
Jan 1, 2018
Anticipated Study Completion Date :
Jan 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: immediate umbilical cord clamping

The control group will receive immediate cord clamping at birth which is the standard of care in our institution

Procedure: immediate umbilical cord clamping
immediate cord clamping without milking as per standard practice
Other Names:
  • standard practice-cord clamping
  • Experimental: Milking the umbilical cord at birth

    Infants in the cord-milked group will be placed at or below the level of the placenta, and about 20 cm of the umbilical cord (or the length of cord that is accessible if less than 20 cm) will be vigorously milked towards the umbilicus three times before clamping the cord.

    Procedure: Milking the umbilical cord at birth
    Infants in the cord-milked group will be placed at or below the level of the placenta, and about 20 cm of the umbilical cord (or the length of cord that is accessible if less than 20 cm) will be vigorously milked towards the umbilicus three times before clamping the cord
    Other Names:
  • Transfusion of blood from umbilical cord to the baby
  • Outcome Measures

    Primary Outcome Measures

    1. Systemic blood flow as reflected by mean SVC flow measured by echocardiographic study at 4-6 hours after birth. [at 4-6 hours of age]

    Secondary Outcome Measures

    1. low SVC flow (< 40 ml/kg/min), as assessed by echocardiography [at 4-6 and 10-12 hours of age]

    2. Hypotension [during the first 48 hours of life]

      Hypotension is defiined as mean blood pressure < corresponding gestational age number for > 30 minutes

    3. Hyperbilirubinemia and peak bilirubin level recording [during first 2 weeks of age]

      Hyperbilirubinemia requiring phototherapy (as per routine unit practice)

    4. Systemic blood flow as reflected by mean SVC flow measured by echocardiographic study at 10-12 hours after birth. [at 10-12 hours of age]

    5. Number of blood transfusions during hospital stay [at 40 weeks of corrected gestational age]

    6. Intraventricular hemorrhage (IVH) [during first 2 weeks of life]

      Intraventricular hemorrhage (IVH) as diagnosed by standard-practice cranial ultrasounds

    7. Neurodevelopmental outcome [At 36 months of age]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    24 Weeks to 31 Weeks
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria:Preterm infants < 31 weeks' gestation if their mothers fulfill the following inclusion criteria:

    1. admitted to the hospital for at least 2 hours before delivery in preterm labor (cervical dilatation >2 cm or having premature rupture of membranes) or if a decision to induce labour has been made by treating physician for a maternal or fetal indications).

    2. at 24+0 weeks - 30+6/7 weeks gestation (by best estimate based on date of last menstrual period or early ultrasound)

    Exclusion Criteria:
    1. monochorionic twin or any higher order multiple pregnancy

    2. major fetal congenital or chromosomal anomalies

    3. significant placental abruption

    4. fetal anemia/transfusion

    5. Rh isoimmunization

    6. intent to withhold or withdraw treatment of the infant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 IWK Health Centre Halifax Nova Scotia Canada

    Sponsors and Collaborators

    • Walid El-Naggar

    Investigators

    • Principal Investigator: Walid I El-Naggar, MD, IWK Health Centre- Dalhousie University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Walid El-Naggar, Primary Investigator, IWK Health Centre
    ClinicalTrials.gov Identifier:
    NCT01487187
    Other Study ID Numbers:
    • 1002554
    First Posted:
    Dec 7, 2011
    Last Update Posted:
    Mar 9, 2017
    Last Verified:
    Mar 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Walid El-Naggar, Primary Investigator, IWK Health Centre
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 9, 2017